• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Telegraph Hill Partners

edit

Telegraph Hill Partners is a private equity firm focused solely on investing in life science, medical device and healthcare companies with growing revenues, superior economic business models, outstanding management teams and a commitment to profitability

Telegraph Hill Partners targets commercial companies in growth areas within the healthcare sector, including life science technologies, medical devices, chemistry and reagent suppliers, healthcare services and information management.

Recent Milestones

edit

• 
  Telegraph Hill Partners invested in RareCyte. (8/21/12)
  Posted 8/22/12 at 7:29pm via yahoo.com
• 
  Telegraph Hill Partners invested in PneumRx. (1/4/11)
  Posted 1/4/11 at 8:33pm via finsmes.com
• 
  Telegraph Hill Partners invested in Estech. (12/7/10)
  Posted 12/7/10 at 6:42pm via finsmes.com
• 
  Telegraph Hill Partners invested in CHF Technologies. (10/1/09)
  Posted 11/5/09 at 7:36pm via venturebeat.com
• 
  Telegraph Hill Partners invested in Estech. (6/3/09)
  Posted 6/17/09 at 12:09pm via venturebeat.com
• 
  Telegraph Hill Partners invested in Estech. (12/17/08)
  Posted 6/15/09 at 12:00pm via smartbrief.com
• 
  Telegraph Hill Partners invested in Asuragen. (12/10/07)
  Posted 3/12/10 at 7:53pm via asuragen.com
• 
  Telegraph Hill Partners invested in AngioScore. (10/9/07)
  Posted 7/15/09 at 5:43am via angioscore.com
• 
  Telegraph Hill Partners invested in Asuragen. (6/1/06)
  Posted 4/19/10 at 10:07pm via asuragen.com
• 
  Telegraph Hill Partners invested in Accumetrics. (7/1/04)
  Posted 2/23/10 at 6:04pm via sec.gov

Investments

Videos

Sources

1. RareCyte Completes Final Tranche of Funding for Launch of its AccuCyte Rare Cell Detection Platform (in.finance.yahoo.com) [edit]
2. PneumRx Raises $33M (finsmes.com) [edit]
3. Estech completes $8.5m Equity Financing (finsmes.com) [edit]
4. CHF Technologies brings in $360K for heart failure treatments (deals.venturebeat.com) [edit]
5. Estech pumps in $8M for heart surgery tools (deals.venturebeat.com) [edit]
6. Endoscopic Technologies raises $11.2M in funding, picks new executives (smartbrief.com) [edit]
7. Asuragen, Inc. Raises $18.5 Million in Series B Financing (asuragen.com) [edit]
8. AngioScore Announces Completion of $30 Million Financing (angioscore.com) [edit]
9. Newly Launched Asuragen Closes Series A Funding of $49 million (asuragen.com) [edit]
10. SEC D/A (sec.gov) [edit]